| 000 | 01380 a2200373 4500 | ||
|---|---|---|---|
| 005 | 20250515152705.0 | ||
| 264 | 0 | _c20090716 | |
| 008 | 200907s 0 0 eng d | ||
| 022 | _a1432-1912 | ||
| 024 | 7 |
_a10.1007/s00210-008-0384-6 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBodei, Serena | |
| 245 | 0 | 0 |
_aShould we be cautious on the use of commercially available antibodies to dopamine receptors? _h[electronic resource] |
| 260 |
_bNaunyn-Schmiedeberg's archives of pharmacology _cApr 2009 |
||
| 300 |
_a413-5 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Validation Study | ||
| 650 | 0 | 4 |
_aAntibodies _ximmunology |
| 650 | 0 | 4 |
_aAntibody Specificity _ximmunology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 | _aCell Line |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aReceptors, Dopamine _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Dopamine D1 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Dopamine D2 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Dopamine D3 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Dopamine D4 _xanalysis |
| 650 | 0 | 4 |
_aReceptors, Dopamine D5 _xanalysis |
| 650 | 0 | 4 | _aTransfection |
| 700 | 1 | _aArrighi, Nicola | |
| 700 | 1 | _aSpano, PierFranco | |
| 700 | 1 | _aSigala, Sandra | |
| 773 | 0 |
_tNaunyn-Schmiedeberg's archives of pharmacology _gvol. 379 _gno. 4 _gp. 413-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1007/s00210-008-0384-6 _zAvailable from publisher's website |
| 999 |
_c18547917 _d18547917 |
||